Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
07:00am, Wednesday, 03'rd Sep 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announ
Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
07:00am, Wednesday, 03'rd Sep 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ fun
Autozi Internet Technology (Global) Ltd. Announces Board and Committee Changes
07:00am, Wednesday, 03'rd Sep 2025
BEIJING , Sept. 3, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd.
Hamilton Lane Launches Global Private Secondary Fund
02:00am, Wednesday, 03'rd Sep 2025
The global evergreen fund for secondaries investment seeks to offer a diversified portfolio of mature private equity investments positioned for value creation by leveraging the firm's 24+ years of exp
WiseTech Global: Growth Re-Acceleration In Sight
05:01pm, Tuesday, 02'nd Sep 2025
I recommend a Buy rating, driven by strong revenue growth and expanding margins in the latest quarter. The company's robust product pipeline and successful market expansion strategies underpin my posi
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
04:45pm, Tuesday, 02'nd Sep 2025
LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automati
SOLOWIN HOLDINGS Announces Intent to Acquire U.S. Licensed Bank to Accelerate Global Financial Expansion
04:30pm, Tuesday, 02'nd Sep 2025
HONG KONG, Sept. 02, 2025 (GLOBE NEWSWIRE) -- via IBN -- SOLOWIN HOLDINGS (NASDAQ: SWIN) (“Solowin” or the “Company”), a leading financial services firm providing comprehensive solutions acros
Global Self Storage Declares Third Quarter 2025 Dividend
04:15pm, Tuesday, 02'nd Sep 2025
MILLBROOK, NY / ACCESS Newswire / September 2, 2025 / Global Self Storage, Inc. (NASDAQ:SELF), a real estate investment trust that owns, operates, manages, acquires, and redevelops self-storage proper
Cycurion to Present at the H.C. Wainwright 27th Annual Global Investment Conference
04:15pm, Tuesday, 02'nd Sep 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a premier cybersecurity and IT solutions provider announces that its Chief Executive O
DES MOINES, Iowa , Sept. 2, 2025 /PRNewswire/ -- F&G Annuities & Life, Inc. (NYSE: FG) today announced that Chris Blunt, Chief Executive Officer, and Conor Murphy, President and Chief Financial Office
Microchip Technology to Present at the Citi 2025 Global TMT Conference
04:15pm, Tuesday, 02'nd Sep 2025
CHANDLER, Arizona, Sept. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announce
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
04:15pm, Tuesday, 02'nd Sep 2025
HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics wit
Ideal Power to Present at H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025
04:11pm, Tuesday, 02'nd Sep 2025
AUSTIN, Texas , Sept. 2, 2025 /PRNewswire/ -- Ideal Power Inc. (Nasdaq: IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and innovative provider of the highly efficient and broadl
Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
04:07pm, Tuesday, 02'nd Sep 2025
LOS ANGELES--(BUSINESS WIRE)--On 9/8/25, Puma Biotechnology CEO and President Alan Auerbach will present a company overview at the H.C. Wainwright Global Investment Conference.
Kairos Pharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference
04:05pm, Tuesday, 02'nd Sep 2025
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that John Yu, MD, CEO and
